ITCI
Intra-Cellular Therapies Inc.
ITCI
ITCI
Delisted
ITCI was delisted on the 1st of April, 2025.
126 hedge funds and large institutions have $298M invested in Intra-Cellular Therapies Inc. in 2019 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 42 increasing their positions, 35 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
41% less call options, than puts
Call options by funds: $15.4M | Put options by funds: $26.2M
Holders
126
Holding in Top 10
–
Calls
$15.4M
Puts
$26.2M
Top Buyers
| 1 | +$12.5M | |
| 2 | +$8.23M | |
| 3 | +$5.87M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$4.18M |
| 5 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
+$2.99M |
Top Sellers
| 1 | -$16M | |
| 2 | -$7.98M | |
| 3 | -$7.79M | |
| 4 |
CCI
Columbus Circle Investors
|
-$6.93M |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
-$2.81M |